PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma

Vladimir Sapon-Cousineau, Sasha Sapon-Cousineau, Sarit Assouline

2020Current Treatment Options in Oncology40 citationsDOI

Topics & Concepts

IdelalisibMedicinePI3K/AKT/mTOR pathwayAdverse effectLymphomaClinical trialTargeted therapyOncologyCancer researchPharmacologyImmunologyInternal medicineCancerSignal transductionChronic lymphocytic leukemiaIbrutinibLeukemiaBiologyBiochemistryChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders research